Prevalence of <i>Pneumocystis jirovecii</i> Colonization in Non-Critical Immunocompetent COVID-19 Patients: A Single-Center Prospective Study (JiroCOVID Study)
Background: <i>Pneumocystis jirovecii</i> pneumonia (PJP) is an invasive fungal infection (IFI) that occurs mainly in immunocompromised hosts. After observing a high prevalence of PJP as a complication of COVID-19 in immunocompetent patients, we conducted a study to evaluate the prevalen...
Main Authors: | Antonio Riccardo Buonomo, Giulio Viceconte, Ludovica Fusco, Marina Sarno, Isabella di Filippo, Luca Fanasca, Paola Salvatore, Ivan Gentile |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/11/12/2839 |
Similar Items
-
Risk Factors for <i>Pneumocystis jirovecii</i> Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study
by: Giulio Viceconte, et al.
Published: (2023-08-01) -
Molecular diagnosis of Pneumocystis jirovecii pneumonia by using External PCR in immunocompromised patients .
by: Arkan A. Al-Qaisi, et al.
Published: (2014-04-01) -
<i>Pneumocystis jirovecii</i> Pneumonia in Children with Hematological Malignancies: Diagnosis and Approaches to Management
by: Elpis Mantadakis
Published: (2020-12-01) -
Determining <i>Pneumocystis jirovecii</i> Colonisation from Infection Using PCR-Based Diagnostics in HIV-Negative Individuals
by: Anna Louise Watson, et al.
Published: (2024-01-01) -
Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway
by: Stine Grønseth, et al.
Published: (2021-07-01)